Top Story

FDA expands approval of Adcetris for advanced classical Hodgkin Lymphoma

March 20, 2018
In the Journals

Lower-limb arterial thrombosis may be marker of cancer

March 20, 2018
Patients with lower-limb arterial thrombosis may be susceptible to development of cancer and, subsequently, cancer mortality, according to findings published in…

Racial minorities with hematologic cancers receive more aggressive end-of-life care

March 20, 2018
Patients with hematologic malignancies received more aggressive

First-line atezolizumab improves PFS for advanced squamous non-small cell lung cancer

March 20, 2018
The addition of frontline atezolizumab to chemotherapy prolonged PFS among patients with advanced squamous non-small cell lung cancer, according to results from an…
In the Journals

Education, care time unaffected by limited work shifts for trainees

March 20, 2018
Limited shifts and workweeks for internal medicine trainees and interns, compared with flexible models that allow first-year residents to work longer hours, do not…
More Headlines »

Ace the Case: 61-Year-Old Male Who Presents to the ER with Worsening Back Pain

There is no commercial support for this activity.

This “Ace the Case” activity will review the diagnosis and management of patients with high-risk multiple…
More »
Meeting News

VIDEO: Meeting offers insights into application of CAR T-cell therapy for hematologic malignancies

March 12, 2018
More »
Resource Centers
HemOnc Today New York

HemOnc Today New York


Benefits and Challenges of Immunotherapy: An Interdisciplinary Perspective

This activity is supported by an educational grant from Bristol-Myers Squibb.

The integration of immunotherapies into management strategies for the treatment of numerous hard-to-treat malignancies…
More »
Current Issues
View the Current Issue
HemOnc Today